Data / Form D filings / Celixir plc
Celixir plc: Form D filing
Celixir plc, a biotechnology company in Stratford-Upon-Avon, United Kingdom, filed a Form D with the SEC in 2018. The latest, on March 21, 2018, reports $1.5 million sold of a $3 million offering to 1 investor.
Find out what Celixir plc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- CELIXIR HOUSE, STRATFORD-UPON-AVON BUSINESS & TECH PARK, Stratford-Upon-Avon, United Kingdom, CV37
- Phone
- (178) 926-9838
- Industry
- Biotechnology
- Entity type
- Other (public limited company)
- Incorporated in
- United Kingdom
- Year incorporated
- 2016
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1735135
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 21, 2018 | New notice | $3,000,000 | $1,500,000 | $1,500,000 | 1 | Mar 6, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Fiona Murray | Director | |
| Conor Kehoe | Director | |
| Gary Pisano | Director | |
| A Reginald | Executive Officer, Director | |
| Mubasher Sheikh | Director | |
| Sabena Sultan | Executive Officer | |
| David Preston | Executive Officer | |
| Martin Evans | Executive Officer, Director | |
| Lee Chapman | Executive Officer | |
| Duncan Ribbons | Executive Officer | |
| Darrin Disley | Director | |
| Chaim Hurvitz | Director | |
| Nigel Scott | Executive Officer |
Every Form D from the week of Mar 19, 2018 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Celixir plc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.